Advancing ALS Drug Development Through the HEALEY ALS Platform Trial: Accelerating Innovation & Collaboration
Time: 8:00 am
day: Conference Day One
Details:
- Highlighting the design and success of the HEALEY ALS Platform Trial in streamlining drug development and improving trial efficiency through a shared infrastructure
- Discussing insights from completed and ongoing regimens, including biomarker discoveries, trial outcomes, and implications for ALS treatment strategies
- Exploring the collaborative framework of the platform, fostering partnerships between academia, industry, and patient communities to drive innovation in ALS therapeutics
